Table 3. Treatment characteristics of patients with a NSCLC in the DLCA-R in 2016 (N=2,427).
Characteristics | N | % |
---|---|---|
Type of radiotherapy | ||
Conventional | 296 | 12.2 |
SBRT | 1294 | 53.3 |
Chemoradiotherapy | 837 | 34.5 |
Of which concurrent | 537 | 64.2 |
SBRT, stereotactic body radiation therapy; DLCA, Dutch Lung Cancer Audit; R, radiotherapeutic-oncologists; NSCLC, non-small cell lung cancer.